文献速递眼底病与葡萄膜炎小儿眼科与斜弱视神经眼科

CEP290或IQCB1致病变异所致Senior-Loken综合征视网膜病变早于INVS、NPHP3或NPHP4变异

Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4.
PubMed 文献 · Am J Ophthalmol · 2023-03-27

该回顾性病例系列纳入74例SLSN相关基因双等位基因变异患者,发现CEP290(61.4%)和IQCB1(28.6%)变异者视网膜病变起病中位年龄约1个月,而INVS、NPHP3或NPHP4变异者先出现肾病;随访中70例转诊肾脏科,62例(88.6%)中位6岁未检出肾单位消耗,8例(11.4%)约9岁出现。

要点

  • CEP290或IQCB1变异者视网膜病变起病早,中位年龄约1个月。
  • INVS、NPHP3或NPHP4变异者先出现肾病。
  • 70例转诊肾脏科者中62例(88.6%)中位6岁未检出肾单位消耗。

核心结论

  • CEP290或IQCB1致病变异患者早期即出现视网膜病变,而INVS、NPHP3或NPHP4变异患者先发生肾病。

研究设计与样本

  • 回顾性病例系列,纳入74例来自70个无亲缘关系家系的SLSN相关基因双等位基因变异患者。

主要发现

  • 74例中检出5个基因变异:CEP290占61.4%、IQCB1占28.6%、NPHP1占4.2%、NPHP4占2.9%、WDR19占2.9%。
  • 视网膜病变起病中位年龄约1个月(自出生起)。
  • CEP290变异者初始体征以眼球震颤最常见(44例中28例,63.6%),IQCB1变异者为22例中19例(86.4%)。
  • 55例中53例(96.4%)视锥和视杆反应熄灭。
  • 随访中74例中70例转诊肾脏科,其中62例(88.6%)中位年龄6岁未检出肾单位消耗,8例(11.4%)约9岁出现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Senior-Loken syndrome (SLSN) is an autosomal recessive disorder characterized by retinopathy and nephronophthisis. This study aimed to evaluate whether different phenotypes are associated with different variants or subsets of 10 SLSN-associated genes based on an in-house data set and a literature review. DESIGN: Retrospective case series. METHODS: Patients with biallelic variants in SLSN-associated genes, including NPHP1, INVS, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8, WDR19, CEP164, and TRAF3IP1, were recruited. Ocular phenotypes and nephrology medical records were collected for comprehensive analysis. RESULTS: Variants in 5 genes were identified in 74 patients from 70 unrelated families, including CEP290 (61.4%), IQCB1 (28.6%), NPHP1 (4.2%), NPHP4 (2.9%), and WDR19 (2.9%). The median age at the onset of retinopathy was approximately 1 month (since birth). Nystagmus was the most common initial sign in patients with CEP290 (28 of 44, 63.6%) or IQCB1 (19 of 22, 86.4%) variants. Cone and rod responses were extinguished in 53 of 55 patients (96.4%). Characteristic fundus changes were observed in CEP290- and IQCB1-associated patients. During follow-up, 70 of the 74 patients were referred to nephrology, among whom nephronophthisis was not detected in 62 patients (88.6%) at a median age of 6 years but presented in 8 patients (11.4%) aged approximately 9 years. CONCLUSIONS: Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy. Therefore, awareness of the genetic and clinical features may facilitate the clinical management of SLSN, especially early intervention of kidney problems for patients with eyes affected first.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wang J, Li S, Jiang Y, et al. Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4. Am J Ophthalmol. 2023. PMID: 36990420. doi:10.1016/j.ajo.2023.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。